Researchers at the Perelman School of Medicine at the University of Pennsylvania have made a significant breakthrough in personalized medicine and cancer treatment. By using patient-derived glioblastoma (GBM) organoids, they have developed a method to model patient responses to CAR-T cell therapy
Certis Oncology Solutions has introduced a groundbreaking innovation: the CertisOI Assistant™, an AI-powered chatbot aimed at significantly enhancing the efficiency of preclinical oncology research. Leveraging the capabilities of artificial intelligence, machine learning (AI/ML), and OpenAI’s
Recent advances in the fight against non-small cell lung cancer (NSCLC) have brought new hope for patients carrying KRAS mutations, thanks to a breakthrough discovery by researchers at UT Southwestern Harold C. Simmons Comprehensive Cancer Center. This advancement revolves around the repurposing of
Respiratory Syncytial Virus (RSV) is a common virus that infects nearly all children by the age of two, but while most cases are mild, some children experience severe respiratory illness that requires hospitalization. The mechanisms behind this severity, especially the role and dysfunction of
Mayo Clinic clinicians are leveraging healthcare-specific large language models (LLMs) and generative artificial intelligence (AI) to enhance patient care and improve clinical decisions. This initiative focuses on the implementation and impact of AI-powered tools within medical research and
Recent research from the University of Alabama at Birmingham (UAB) has unveiled groundbreaking insights into the replication mechanism of the BK polyomavirus (BKPyV), a major cause of kidney transplant failure. This discovery could pave the way for new treatments to protect transplanted kidneys
